However, B cells displayed differently in patients with IgG4-RD and pSS, including disturbed B-cell subpopulations and key signaling molecules, such as CD40, CD86, CD80 and BAFF-R. This evidence concerns the gene TNFRSF13C and immunoglobulin G4-related sclerosing disease.